Francis H Y Green Selected Research

perfluorooctylbromide and CO2 drug combination

6/2018	A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
1/2016	A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francis H Y Green Research Topics

Disease

14	Asthma (Bronchial Asthma) 01/2020 - 01/2002
8	Pneumoconiosis 01/2023 - 12/2004
8	Lung Diseases (Lung Disease) 01/2023 - 01/2003
5	Inflammation (Inflammations) 10/2023 - 11/2002
5	Anthracosis 10/2023 - 12/2004
5	Fibrosis (Cirrhosis) 10/2023 - 06/2009
4	Emphysema 08/2009 - 01/2005
3	Silicosis 01/2023 - 12/2004
2	Berylliosis 01/2023 - 12/2004
2	Asbestosis 01/2023 - 12/2004
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2014 - 01/2003
2	Chronic Bronchitis 06/2009 - 12/2008
2	Metaplasia 06/2008 - 11/2002
1	Dyspnea (Shortness of Breath) 11/2019
1	Hepatitis 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Respiratory Hypersensitivity 10/2018
1	Hypocapnia 07/2011
1	Hypercapnia 07/2011
1	Infections 10/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2008
1	Obstructive Lung Diseases (Obstructive Lung Disease) 12/2008
1	Cicatrix (Scar) 12/2008
1	Idiopathic Pulmonary Fibrosis 12/2008
1	Postmortem Changes (Adipocere) 06/2008
1	Tuberculosis (Tuberculoses) 01/2005
1	Bronchitis 01/2005
1	Airway Remodeling 04/2004
1	Acute Lung Injury 01/2003
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2003

Drug/Important Bio-Agent (IBA)

12	Coal (Coals)IBA 10/2023 - 01/2005
5	AllergensIBA 10/2018 - 01/2002
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023 - 12/2008
2	hard metalIBA 01/2023 - 12/2004
2	Phenobarbital (Luminal)FDA Link 01/2020 - 10/2006
2	perfluorooctylbromide and CO2 drug combinationIBA 06/2018 - 01/2016
2	SilicatesIBA 03/2016 - 12/2004
2	Insulin-Like Growth Factor I (IGF-1)IBA 11/2014 - 01/2003
2	SmokeIBA 01/2011 - 12/2008
2	Proteins (Proteins, Gene)FDA Link 06/2008 - 01/2003
1	Particulate MatterIBA 01/2023
1	phytobacteriomycin (PBM)IBA 12/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Concanavalin AIBA 01/2019
1	Prostaglandins AIBA 12/2018
1	lysophosphatidic acidIBA 10/2018
1	Lysophosphatidic Acid ReceptorsIBA 10/2018
1	Bronchodilator Agents (Bronchodilators)IBA 06/2018
1	SolutionsIBA 01/2016
1	CalciumIBA 07/2011
1	Substance PIBA 07/2011
1	CarbonIBA 01/2011
1	Air Pollutants (Pollutants, Air)IBA 10/2010
1	MineralsIBA 06/2009
1	Aluminum SilicatesIBA 06/2009
1	Messenger RNA (mRNA)IBA 06/2008
1	Complementary DNA (cDNA)IBA 06/2008
1	RNA (Ribonucleic Acid)IBA 06/2008
1	Rubber (Elastica)IBA 10/2006
1	Surface-Active Agents (Surfactants)IBA 05/2006
1	Silicone Elastomers (SE 30)IBA 10/2005
1	Diatomaceous Earth (Kieselguhr)IBA 12/2004
1	ferric oxide (iron oxide)IBA 12/2004
1	Aluminum Oxide (Sapphire)IBA 12/2004
1	carborundumIBA 12/2004
1	milk-derived factorIBA 12/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2004
1	OvalbuminIBA 04/2004
1	P-SelectinIBA 11/2002
1	Transcription Factors (Transcription Factor)IBA 01/2002

Therapy/Procedure

3	Bronchial Thermoplasty 11/2019 - 01/2018
1	Lung Transplantation 11/2019
1	Bronchoscopes 01/2019
1	Ligation 01/2019
1	Denervation 10/2018
1	Therapeutics 01/2018